Skip to main content

Table 1 Patient features

From: Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients

Variable

Frequency

%

All patients

21 (16-37)

Ā 

Median recipient age (years, range)

Gender

Ā Ā 

ā€ƒMale

16/34

47

ā€ƒFemale

18/34

53

Death

9/34

27

Rejection

0

0

Grade II-IV acute GVHD (in dead pts)

6/9

67

Grade II-IV acute GVHD (in live pts)

3/25

12

Chronic GVHD

3/25

12

Alive with graft

25/34

73

Gender

Ā Ā 

ā€ƒMale

12/25

48

ā€ƒFemale

13/25

52

Median test age (years, range)

25 (18-35)

Ā 

ā€ƒā€‰ā‰¤ā€‰20

13

52

ā€ƒā€‰ā‰„ā€‰20

12

48

School level at the time of HSCT

Ā Ā 

ā€ƒHigh

14/25

56

ā€ƒLow

11/25

44

  1. GVHD: Graft Versus Host Disease.